MedPath

SIPERSTEIN DERMATOLOGY

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:1
Completed:2

Trial Phases

1 Phases

Not Applicable:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Not Applicable
4 (100.0%)

Post-Procedural Biotech Cellulose Mask

Not Applicable
Completed
Conditions
Temperature Change, Body
First Posted Date
2023-10-03
Last Posted Date
2023-10-03
Lead Sponsor
Siperstein Dermatology
Target Recruit Count
15
Registration Number
NCT06065332
Locations
🇺🇸

Siperstein Dermatology Group, Boynton Beach, Florida, United States

Vollure for the Correction of Atrophic Facial Scarring

Not Applicable
Conditions
Atrophic Scar
First Posted Date
2020-08-19
Last Posted Date
2022-02-15
Lead Sponsor
Siperstein Dermatology
Target Recruit Count
15
Registration Number
NCT04519515
Locations
🇺🇸

Siperstein Dermatology Group, Boynton Beach, Florida, United States

Restylane Refyne for Correction of Horizontal Neck Rhytides

Not Applicable
Active, not recruiting
Conditions
Aging
Wrinkle
Rhytides
First Posted Date
2019-11-14
Last Posted Date
2021-06-08
Lead Sponsor
Siperstein Dermatology
Target Recruit Count
24
Registration Number
NCT04162496
Locations
🇺🇸

Siperstein Dermatology, Boynton Beach, Florida, United States

Broad Band Light for the Treatment and Prevention of Senile Purpura

Not Applicable
Completed
Conditions
Bateman's Purpura
Senile Purpura
First Posted Date
2018-10-01
Last Posted Date
2021-04-13
Lead Sponsor
Siperstein Dermatology
Target Recruit Count
10
Registration Number
NCT03690375
Locations
🇺🇸

Siperstein Dermatology Group, Boynton Beach, Florida, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.